Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
1.020
+0.281 (38.02%)
At close: Sep 4, 2026, 4:00 PM EDT
0.8071
-0.2130 (-20.87%)
After-hours: Sep 4, 2026, 7:59 PM EDT
Onconetix Market Cap
Onconetix has a market cap or net worth of $4.03 million as of September 4, 2026. Its market cap has decreased by -11.36% in one year.
Market Cap
4.03M
Enterprise Value
-1.73M
1-Year Change
-11.36%
Ranking
Category
Stock Price
$1.02
ChartMarket Cap Chart
Since the IPO on February 18, 2022, Onconetix's market cap has decreased from $624.51M to $4.03M, a decrease of -99.35%. That is a compound annual growth rate of -67.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 4.03M | 66.05% |
| Dec 31, 2025 | 2.43M | -53.56% |
| Dec 31, 2024 | 5.22M | 43.70% |
| Dec 29, 2023 | 3.64M | -78.64% |
| Dec 30, 2022 | 17.02M | -97.28% |
| Feb 18, 2022 | 624.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 60 Degrees Pharmaceuticals | 3.34M |
| Aptevo Therapeutics | 3.21M |
| Artelo Biosciences | 3.13M |
| Jaguar Health | 3.09M |
| SciSparc | 3.00M |
| Genprex | 2.85M |
| Curis | 2.79M |
| Valion Bio | 2.63M |